Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31, 2026.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lincoln Pharmaceuticals Limited has published its audited financial results (standalone and consolidated) for Q4 and full year FY26 ended March 31, 2026. The Board of Directors approved these results at their meeting held on May 28, 2026. The company published this as a newspaper advertisement in Financial Express (English and Gujarati editions) in compliance with SEBI Listing Regulations. The full financial results along with the auditors report have been hosted on the company's website and stock exchange websites. Due to OCR limitations, the specific revenue, profit, and EPS figures could not be extracted from this filing.
This is a routine year-end financial results announcement. The actual financial performance data needs to be accessed from the company's investor relations website or stock exchange portals to assess impact on shareholders.